Chromatin Immunoprecipitation (ChIP) News and Research

RSS

Organ-on-a-chip could replace use of animals to test drugs for safety and efficacy

When University of California, Berkeley, bioengineers say they are holding their hearts in the palms of their hands, they are not talking about emotional vulnerability.

12 Mar 2015

2U, Yale University partner to launch online Master of Medical Science degree for PA

2U, Inc., today announced that it is partnering with Yale University to launch an online Master of Medical Science (MMSc) degree for aspiring physician associates (PA), pending approval of the online program by the Accreditation Review Commission on Education for the Physician Assistant and various state licensing agencies.

10 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

Chiasma closes $70 million Series E financing round

Chiasma, Inc., a U.S. privately-held biopharma company developing octreotide capsules, its lead product for the orphan condition acromegaly, today announced the closing of a $70 million Series E financing round.

27 Feb 2015

Genomics researchers discover novel gene variants in childhood CVID

Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).

27 Feb 2015

Simple paper strip test can rapidly diagnose Ebola

When diagnosing a case of Ebola, time is of the essence. However, existing diagnostic tests take at least a day or two to yield results, preventing health care workers from quickly determining whether a patient needs immediate treatment and isolation.

25 Feb 2015

Developments in ChIP technology

Biowales, one of the UK’s leading events for the life sciences sector, this year will focus on the life sciences supply chain providing practical commercial opportunities for growth through novel routes to market in the private sector and National Health Service (NHS).

From Chromatrap® - Porvair Sciences Ltd 24 Feb 2015

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

23andMe, Inc., the leading personal genetics company, today announced that it has been granted authority by the U.S. Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test under a regulatory classification for novel devices.

20 Feb 2015

New study demonstrates cost-saving, health care quality outcomes of pediatric ACO

A new study published in Pediatrics demonstrates the cost-saving and health care quality outcomes of the pediatric Accountable Care Organization Partners for Kids. Results of this study indicate that Partners for Kids successfully improved the value of pediatric healthcare over time through cost containment, while maintaining quality of care.

18 Feb 2015

Smart watch that remotely monitors real-time health status of older adults

The trend of wearable devices (smart accessories) like bracelets, sunglasses and watches, is rarely focused on the elderly population. However, Mexican Francisco Lopez-Lira Fennel, who lives in Spain, wants these devices to be used by older adults benefiting them with the first smart watch that remotely monitors real-time health status.

9 Feb 2015

Artificial mini-organism: An alternative to animal testing

No one wishes to dispense with the blessings of modern medicine, which took away the dread of many diseases. The flipside of the coin: To ensure that effective and safe medications are available, experiments on animals in research laboratories are indispensable.

9 Feb 2015

Colored electronic wristbands speed up triage of victims during mass casualty incidents

A new system aims to speed up the triage of victims during mass casualty incidents: Instead of colored paper tags, first responders use colored electronic wristbands.

9 Feb 2015

Recession of mid-2000s continues to impact America's children

The bipartisan children's advocacy organization First Focus and PolicyLab at The Children's Hospital of Philadelphia released a new analysis today showing that, five years after its technical end, the recession of the mid-2000s continues to impact America's children.

4 Feb 2015

Cities with Super Bowl teams see big spike in flu illness, deaths

Boston and Seattle football fans beware! Cities with teams in the Super Bowl see a big spike in flu deaths, according to a new Tulane University study.

31 Jan 2015

Medifast recognized as a 2015 Future 50 Blue Chip company by SmartCEO magazine

Medifast, Inc., a leading United States manufacturer and provider of clinically proven, weight-loss and healthy living products and programs is proud to be recognized by SmartCEO magazine as a 2015 Future 50 Blue Chip company for the fourth consecutive year.

21 Jan 2015

Chromatrap announce solid state ChIP kits

Chromatrap®, a business unit of Porvair Sciences, has an announced solid state ChIP kits which rapidly improve chromatin immunoprecipitation (ChIP) through a unique patented technology that streamlines the process, ensuring chromatin preparation to qPCR analysis can be performed in under five hours.

From Chromatrap® - Porvair Sciences Ltd 19 Jan 2015

Mobile diagnosis device to help reduce unnecessary antibiotics prescribing

New biosensor-based technology could help to reduce the over-prescribing of antibiotics by giving GPs and other frontline healthcare staff an accurate and fast method of identifying the nature of infectious diseases.

15 Jan 2015

New opportunity for developing simple test to measure E2F4 activity in ER+ breast cancer patients

By looking at the expression levels of downstream genes of the regulators in breast cancer, investigators at Dartmouth Hitchcock's Norris Cotton Cancer Center, led by Chao Cheng, PhD, have identified a gene signature in E2F4 that is predictive of estrogen receptor positive (ER+) breast cancer.

8 Jan 2015

MagnaChip launches new bio-sensor research collaboration

MagnaChip Semiconductor Corporation, a Korea-based designer and manufacturer of analog and mixed-signal semiconductor products, today announced it has launched a research collaboration focused on developing innovative, cost-effective silicon magnetic bio-sensor technology capable of monitoring extremely rare cells in blood.

30 Dec 2014

U-M researchers devise reliable way to grow tumor cells

In a development that could lead to a deeper understanding of cancer and better early-stage treatment of the disease, University of Michigan researchers have devised a reliable way to grow a certain type of cancer cells from patients outside the body for study.

18 Dec 2014

Chromatin Immunoprecipitation (ChIP) News and Research

Organ-on-a-chip could replace use of animals to test drugs for safety and efficacy

2U, Yale University partner to launch online Master of Medical Science degree for PA

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Chiasma closes $70 million Series E financing round

Genomics researchers discover novel gene variants in childhood CVID

Simple paper strip test can rapidly diagnose Ebola

Developments in ChIP technology

23andMe granted FDA approval to market direct-to-consumer genetic test under novel device classification

New study demonstrates cost-saving, health care quality outcomes of pediatric ACO

Smart watch that remotely monitors real-time health status of older adults

Artificial mini-organism: An alternative to animal testing

Colored electronic wristbands speed up triage of victims during mass casualty incidents

Recession of mid-2000s continues to impact America's children

Cities with Super Bowl teams see big spike in flu illness, deaths

Medifast recognized as a 2015 Future 50 Blue Chip company by SmartCEO magazine

Chromatrap announce solid state ChIP kits

Mobile diagnosis device to help reduce unnecessary antibiotics prescribing

New opportunity for developing simple test to measure E2F4 activity in ER+ breast cancer patients

MagnaChip launches new bio-sensor research collaboration

U-M researchers devise reliable way to grow tumor cells

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News